2020, Number 3
Next >>
Rev Biomed 2020; 31 (3)
The new normal of medical research: replicability and reproducibility
González-Rayas JM, Rayas-Gómez AL, González-Yáńez JM, García-González JJ, Hernández-Hernández JA, López-Sánchez RC
Language: Spanish
References: 6
Page: 108-110
PDF size: 471.36 Kb.
Text Extraction
No abstract.
REFERENCES
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. En prensa.
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. En prensa.
Off ord C. Surgisphere Sows Confusion About Another Unproven COVID-19 Drug. The Scientist. 2020 June 16. News & Opinion. Available from: https://www. thescientist. com/news-opinion/surgisphere-sowsconfusionabout- another-unproven-covid19-drug-67635
National Academies of Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science. Washington (D C): National Academies Press; 2019.
Petersen OH. Reproducibility – again. J Physiol. 2019 Feb; 597(3): 657–8. doi: 10.1113/JP277486
Wagner PD. Cores of Reproducibility in Physiology (CORP): Advancing the corpus of physiological knowledge. J Appl Physiol. 2017 Ene; 122(1): 89–90. doi: 10.1152/japplphysiol.01046.2016.
Full text